Streetbeat News

Stock Prices

AHCO

AdaptHealth (NASDAQ:AHCO) has received mixed analyst ratings in the last quarter, with 2 bullish, 1 indifferent, and 1 somewhat bearish. The company's average 12-month price target is $10.62, a 29.2% decrease from the previous average of $15.00.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 5:00 pm

CBAY

Raymond James has maintained its Strong Buy rating for CymaBay Therapeutics (NASDAQ:CBAY) and increased its price target from $33.00 to $34.00. This new target represents a 106.56% increase from the current share price. CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 5:00 pm

BBVA

BBVA's short percent of float has fallen 20.0% since its last report, with 2.43 million shares sold short, which is 0.04% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards BBVA. Compared to its peers, BBVA has less short interest as a percentage of float, with an average of 0.82%.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 5:00 pm

ABNB

BKNG

MAR

Airbnb, Marriott, and Booking have all reported strong Q3 results, indicating a robust demand for travel. Airbnb's revenue grew 18% YoY to $3.40 billion, but its Q4 guidance fell short of estimates, causing a 3% drop in shares. Marriott reported 6-8% growth in revenue per available room globally, with a net income of $752 million. Booking's Q3 revenue grew 21% to $7.3 billion, despite a slowdown due to the Israeli-Hamas conflict.

Portfolio Pulse from Upwallstreet

November 08, 2023 | 4:55 pm

MIDD

Middleby Corp reported a 1.2% YoY decline in Q3 FY23 net sales to $980.65 million, missing the consensus of $1.02 billion. The company's adjusted EPS improved by 8% YoY to $2.35, beating the consensus of $2.31. The company is facing challenges due to inventory de-stocking and rising interest rates. Despite this, MIDD shares traded higher by 2.25% at $117.03.

Portfolio Pulse from Akanksha Bakshi

November 08, 2023 | 4:55 pm

PAAS

Pan American Silver reported its Q3 financial results, which led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 4:50 pm

CAVA

CAVA Group reported its Q3 financial results, following which its shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 4:49 pm

VTEX

VTEX has issued strong Q4 guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 4:47 pm

C

Citigroup (NYSE:C) has seen unusual options activity, with 54% of traders showing bullish tendencies and 45% bearish. The big players have been eyeing a price window from $30.0 to $55.0 for Citigroup during the past quarter. The price of C is currently down -0.33% at $41.82. Analysts from BMO Capital, Piper Sandler, and Oppenheimer maintain Outperform and Neutral ratings on Citigroup with target prices of $66, $45, and $82 respectively.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 4:46 pm

JD

A significant bullish stance has been taken on JD.com (NASDAQ:JD) by a large investor, as indicated by a large position appearing in publicly available options history. The overall sentiment of these big-money traders is split between 63% bullish and 36% bearish. The major market movers are focusing on a price band between $25.0 and $40.0 for JD.com. Barclays, UBS, and Goldman Sachs maintain a positive rating on JD.com, while Bernstein and Morgan Stanley have revised their ratings downward.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 4:46 pm